Phio Pharmaceuticals CEO Robert Bitterman | Interview with Jane King on PH-762 and INTASYL
8:00
Phio Pharmaceuticals CEO Robert Bitterman | Interview with Jane King on PH-762 and INTASYL
1.1K views1 week ago
YouTubeB2i Digital, Inc.
Phio Pharmaceuticals (NASDAQ: PHIO) Robert Bitterman and Jane King Interview - Clip 1
0:39
Phio Pharmaceuticals (NASDAQ: PHIO) Robert Bitterman and Jane King Interview - Clip 1
1.2K views1 week ago
YouTubeB2i Digital, Inc.
Phio Pharmaceuticals (NASDAQ: PHIO) receives three notices of allowance and one grant decision
0:40
Phio Pharmaceuticals (NASDAQ: PHIO) receives three notices of allowance and one grant decision
1.6K views3 weeks ago
YouTubeB2i Digital, Inc.
Phio Pharmaceuticals begins first commercial-scale cGMP production of PH-762 drug substance.
0:34
Phio Pharmaceuticals begins first commercial-scale cGMP production of PH-762 drug substance.
2.7K views1 month ago
YouTubeB2i Digital, Inc.
The team at B2i Digital welcomes Phio Pharmaceuticals Corp. (NASDAQ: PHIO) as a new Featured Company
0:13
The team at B2i Digital welcomes Phio Pharmaceuticals Corp. (NASDAQ: PHIO) as a new Featured Company
1.3K views5 months ago
YouTubeB2i Digital, Inc.
Phio Pharmaceuticals (NASDAQ: PHIO) Robert Bitterman and Jane King Interview - Clip 2
0:43
Phio Pharmaceuticals (NASDAQ: PHIO) Robert Bitterman and Jane King Interview - Clip 2
735 views1 week ago
YouTubeB2i Digital, Inc.
Phio Pharmaceuticals (NASDAQ: PHIO) | Virtual Non-Deal Roadshow | Renmark Financial Communications
39:19
Phio Pharmaceuticals (NASDAQ: PHIO) | Virtual Non-Deal Roadshow | Renmark Financial Communications
39 views2 months ago
YouTubeRenmark Financial Communciations
1:35
Phio Pharmaceuticals Corp. PH-762 silences PD-1 inside a tumor to help the immune system attack cancer. Robert Bitterman, President and CEO of Phio Pharmaceuticals Corp. (NASDAQ: PHIO), used a Force Family Office webinar to explain how the company's lead candidate, PH-762, works. The drug targets PD-1, a protein that tumors use to switch off the immune system's T cells, by silencing the gene that produces it so those T cells can recognize the tumor and attack it. Phio Pharmaceuticals Corp. is a
30 views1 month ago
TikTokb2idigital
31:15
Life Sciences Virtual Investor Forum — Phio Pharmaceuticals Corp. (Nasdaq: PHIO)
278 views4 months ago
YouTubeB2i Digital, Inc.
30:25
Phio Pharmaceuticals Corp. (NASDAQ: PHIO): Virtual Investor Conferences
27 views1 month ago
YouTubeOTC Markets Group
See more
Static thumbnail place holder